Latest News and Press Releases

Conference Call and Webcast Today at 8:30 a.m. ET Initiated dosing in OCU410ST Phase 2/3 GARDian3 pivotal confirmatory clinical trialActively dosing patients in OCU400 Phase 3 liMeliGhT clinical...

ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing...

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Glaucoma - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering. The clinical trial report offers a...

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The...

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Contract Research Organization Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The ophthalmology...

- XIPERE Now Approved for Use in Multiple Global Markets - - Continued Global Expansion and Validation of Clearside’s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS...

MALVERN, Pa., July 18, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...

MALVERN, Pa., July 17, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that...

Exton, Pennsylvania, July 10, 2025 (GLOBE NEWSWIRE) -- Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape...

Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Glaucoma Therapeutics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)" has been added to ...